Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success

by Cazzaniga, Marina Elena, Danesi, Romano, Girmenia, Corrado, Invernizzi, Pietro, Elvevi, Alessandra, Uguccioni, Massimo
Published in Breast Cancer Res Treat (2019)

Metronomic Chemotherapy

by Cazzaniga, Marina Elena, Cordani, Nicoletta, Capici, Serena, Cogliati, Viola, Riva, Francesca, Cerrito, Maria Grazia
Published in Cancers (Basel) (2021)

Molecular and Immune Biomarkers for Cutaneous Melanoma: Current Status and Future Prospects

by Pilla, Lorenzo, Alberti, Andrea, Di Mauro, Pierluigi, Gemelli, Maria, Cogliati, Viola, Cazzaniga, Marina Elena, Bidoli, Paolo, Maccalli, Cristina
Published in Cancers (Basel) (2020)

The Role for Tocilizumab in COVID-19 Patients: Reflections on Monza Cohort Data

by Capici, Serena, Sala, Luca, Galimberti, Stefania, Valsecchi, Maria Grazia, Squillace, Nicola, Gustinetti, Giulia, Cazzaniga, Marina Elena, Bonfanti, Paolo
Published in Infect Drug Resist (2021)

Comparison of tumor microenvironment in primary and paired metastatic ER+/HER2- breast cancers: results of a pilot study

by Zeppellini, Annalisa, Galimberti, Stefania, Leone, Biagio Eugenio, Pacifico, Claudia, Riva, Francesca, Cicchiello, Federica, Capici, Serena, Maggioni, Claudia, Sala, Luca, Cazzaniga, Marina Elena
Published in BMC Cancer (2021)

Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study

by Cerrito, Maria Grazia, De Giorgi, Marco, Pelizzoni, Davide, Bonomo, Sara Maria, Digiacomo, Nunzio, Scagliotti, Arianna, Bugarin, Cristina, Gaipa, Giuseppe, Grassilli, Emanuela, Lavitrano, Marialuisa, Giovannoni, Roberto, Bidoli, Paolo, Cazzaniga, Marina Elena
Published in Oncotarget (2018)

Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?

by Cazzaniga, Marina Elena, Biganzoli, Laura, Cortesi, Laura, De Placido, Sabino, Donadio, Michela, Fabi, Alessandra, Ferro, Antonella, Generali, Daniele, Lorusso, Vito, Milani, Andrea, Montagna, Emilia, Munzone, Elisabetta, Orlando, Laura, Pizzuti, Laura, Simoncini, Edda, Zamagni, Claudio, Pappagallo, Giovanni L
Published in Onco Targets Ther (2019)

Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study

by Di Cosimo, Serena, La Verde, Nicla, Moretti, Anna, Cazzaniga, Marina Elena, Generali, Daniele, Bianchi, Giulia Valeria, Mariani, Luigi, Torri, Valter, Crippa, Flavio, Paolini, Biagio, Scaperrotta, Gianfranco, De Santis, Maria Carmen, Di Nicola, Massimo, Apolone, Giovanni, Gulino, Alessandro, Tripodo, Claudio, Colombo, Mario Paolo, Folli, Secondo, de Braud, Filippo
Published in PLoS One (2019)